PHARMACOKINETIC AND PHARMACOLOGICAL VARIATION BETWEEN DIFFERENT ESTROGEN PRODUCTS

被引:140
作者
OCONNELL, MB
机构
[1] University of Minnesota College of Pharmacy, Minneapolis, Minnesota
关键词
D O I
10.1002/j.1552-4604.1995.tb04143.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Due to the complex nature of endogenous and exogenous hormone concentrations, formation, and metabolism and assay complexity, the pharmacokinetics of estrogens are difficult to study. Oral estrogens have minimal systemic bioavailability (2% to 10%) due to gut and liver (first-pass) metabolism. High concentrations of estrone are achieved with oral administration, whereas higher concentrations of estradiol are generally achieved after percutaneous absorption. Although vaginal products (such as gel, rings, etc.) are administered locally, they achieve high serum concentrations. Estradiol and estrone concentrations and estradiol-to-estrone ratios vary with different estrogen therapies. Approximately 95% to 98% of estradiol is bound loosely to albumin or tightly to sex hormone binding globulin, the major binding protein. The terminal half lives for the different estrogen compounds (after oral or intravenous administration) vary from 1-12 hours. Some conversion rates have been calculated between estrogen and its metabolites. Smoking decreases achievable estrogen concentrations, and has a greater effect on oral products. Oral contraceptives have been found to decrease antipyrine clearance. In the one study evaluating conjugated estrogens, antipyrine clearance was not altered. Oral contraceptives have a variable effect on the elimination of medications. Acetaminophen clearance is increased, whereas clearance of some benzodiazepines, caffeine, and prednisolone is decreased. Phenytoin increases the metabolism of conjugated estrogens. The various estrogen products may produce different clinical effects based on composition. The metabolites (minor components) of conjugated estrogens have been found to have significant effects on lipid concentrations, uterine weight, liver generated compounds, and bone resorption. Because transdermal products bypass the first-pass effect, delayed or decreased effects on lipid profiles and liver generated compounds have been observed.
引用
收藏
页码:S18 / S24
页数:7
相关论文
共 45 条
  • [1] IMPAIRMENT OF ANTIPYRINE METABOLISM BY LOW-DOSE ORAL-CONTRACEPTIVE STEROIDS
    ABERNETHY, DR
    GREENBLATT, DJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (01) : 106 - 110
  • [2] PHARMACOKINETICS OF EQUILIN AND EQUILIN SULFATE IN NORMAL POST-MENOPAUSAL WOMEN AND MEN
    BHAVNANI, BR
    WOOLEVER, CA
    BENOIT, H
    WONG, T
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 56 (05) : 1048 - 1056
  • [3] PHARMACOKINETICS OF 17-BETA-DIHYDROEQUILIN SULFATE AND 17-BETA-DIHYDROEQUILIN IN NORMAL POSTMENOPAUSAL WOMEN
    BHAVNANI, BR
    CECUTTI, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (01) : 197 - 204
  • [4] METABOLIC-CLEARANCE RATE OF EQUILIN SULFATE AND ITS CONVERSION TO PLASMA EQUILIN, CONJUGATED AND UNCONJUGATED EQUILENIN, 17-BETA-DIHYDROEQUILIN, AND 17-BETA-DIHYDROEQUILENIN IN NORMAL POSTMENOPAUSAL WOMEN AND MEN UNDER STEADY-STATE CONDITIONS
    BHAVNANI, BR
    CECUTTI, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (05) : 1269 - 1274
  • [5] BYRJALSEN I, 1993, OBSTET GYNECOL, V81, P1016
  • [6] SERUM ESTRONE CONCENTRATIONS AND CORONARY-ARTERY DISEASE IN POSTMENOPAUSAL WOMEN
    CAULEY, JA
    GUTAI, JP
    GLYNN, NW
    PATERNOSTROBAYLES, M
    COTTINGTON, E
    KULLER, LH
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (01): : 14 - 18
  • [7] RELIABILITY AND INTERRELATIONS AMONG SERUM SEX-HORMONES IN POSTMENOPAUSAL WOMEN
    CAULEY, JA
    GUTAI, JP
    KULLER, LH
    POWELL, JG
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 133 (01) : 50 - 57
  • [8] ENDOGENOUS ESTROGEN-LEVELS AND CALCIUM INTAKES IN POSTMENOPAUSAL WOMEN - RELATIONSHIPS WITH CORTICAL BONE MEASURES
    CAULEY, JA
    GUTAI, JP
    KULLER, LH
    LEDONNE, D
    SANDLER, RB
    SASHIN, D
    POWELL, JG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (21): : 3150 - 3155
  • [9] ANTIPYRINE ELIMINATION IN SALIVA AFTER LOW-DOSE COMBINED OR PROGESTOGEN-ONLY ORAL-CONTRACEPTIVE STEROIDS
    CHAMBERS, DM
    JEFFERSON, GC
    CHAMBERS, M
    LOUDON, NB
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (02) : 229 - 232
  • [10] BIOLOGIC EFFECTS OF TRANSDERMAL ESTRADIOL
    CHETKOWSKI, RJ
    MELDRUM, DR
    STEINGOLD, KA
    RANDLE, D
    LU, JK
    EGGENA, P
    HERSHMAN, JM
    ALKJAERSIG, NK
    FLETCHER, AP
    JUDD, HL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (25) : 1615 - 1620